A detailed history of Pale Fire Capital Se transactions in Chimerix Inc stock. As of the latest transaction made, Pale Fire Capital Se holds 254,963 shares of CMRX stock, worth $851,576. This represents 0.04% of its overall portfolio holdings.

Number of Shares
254,963
Previous 166,207 53.4%
Holding current value
$851,576
Previous $146 Million 62.86%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.77 - $1.07 $68,342 - $94,968
88,756 Added 53.4%
254,963 $237 Million
Q2 2024

Aug 13, 2024

BUY
$0.87 - $1.05 $53,427 - $64,481
61,411 Added 58.6%
166,207 $146 Million
Q1 2024

May 14, 2024

SELL
$0.91 - $1.26 $96,840 - $134,086
-106,418 Reduced 50.38%
104,796 $111 Million
Q4 2023

Feb 13, 2024

BUY
$0.9 - $1.06 $101,086 - $119,057
112,318 Added 113.57%
211,214 $203 Million
Q3 2023

Nov 13, 2023

BUY
$0.94 - $1.23 $92,962 - $121,642
98,896 New
98,896 $94.9 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $293M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.